Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126913
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2023-09-27
Brief Title:
HeadStART Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Achieving HIV Viral Suppression in Refugee Settlements in Uganda With Head StART A Cluster Randomized Trial Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HeadStART
Brief Summary:
This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy ART delivery to people newly diagnosed with HIV in achieving HIV viral suppression
Detailed Description:
Community antiretroviral therapy ART delivery is a differentiated care model that fosters social support and reduces time and transportation barriers yielding improved engagement in HIV care In Uganda to participate in community ART delivery clients must be stable in care 1 year on ART and viral load 1000 copiesmL Therefore persons newly diagnosed with HIV are not eligible for community ART delivery Community ART delivery may benefit persons newly diagnosed with HIV in refugee settlements by bolstering social support and by bringing ART closer to individuals living in these expansive rural settlements The primary objective of this research is to evaluate the effectiveness of expanding community ART delivery to clients newly diagnosed with HIV
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01MH130216 | NIH | None | httpsreporternihgovquickSearchR01MH130216 |